ERIC LOOS: Open Payments
NPI 1982396347 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$563 in 26 payments from 20 companies in 2025. Trend: 2023 $240 · 2024 $474 · 2025 $563
Food & beverage: $467Education: $96
| Company | Payments | Amount |
|---|---|---|
| SEAGEN INC. | 1 | $80 |
| BeOne Medicines USA, Inc. | 3 | $52 |
| Regeneron Healthcare Solutions, Inc. | 1 | $39 |
| Novartis Pharmaceuticals Corporation | 2 | $36 |
| ABBVIE INC. | 2 | $34 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| PFIZER INC. | 2 | $33 |
| TerSera Therapeutics LLC | 1 | $31 |
| AstraZeneca Pharmaceuticals LP | 1 | $29 |
| SERVIER PHARMACEUTICALS LLC | 1 | $23 |
Products named: LYNOZYFIC, TEVIMBRA, JEMPERLI, Zoladex, ENHERTU, Voranigo, Amtagvi, Venclexta.
Industry payments across NE — which companies pay providers there.
